Ashwani Singal
Professor of Medicine University of Louisville
Seminars
Thursday 16th April 2026
Unlocking the Potential of GLP-1s to Treat Addiction & Substance Use Disorders to Reduce Cravings & Impulsivity to Provide a Novel Treatment Option
10:00 am
- Modulating brain reward circuits to reduce cravings and impulsivity, offering a novel, non-addictive therapeutic option for substance use disorders
- Expanding the therapeutic scope of GLP-1s to offer a new treatment for addiction to help address a major public health crisis with a new mechanism
- Integrating GLP-1 therapy with behavioural interventions to enhance treatment efficacy, leading to better patient outcomes and a higher rate of long-term recovery
Thursday 16th April 2026
Fire-Side Discussion: Repurposing GLP-1s to Treat Alzheimer’s & Parkinson’s to Improve Cognitive Function & Reduce Neuroinflammation to Create a New Therapeutic Avenue
12:00 pm
- Diversifying treatment opportunities by investigating GLP-1s for new indications like neurological disorders and addiction to unlock their full therapeutic potential and expand their use beyond cardiometabolic health
- Providing new hope for patients by researching next-generation applications to create therapeutic options for conditions with limited treatments
- Expanding the clinical horizon with a wider range of applications for GLP-1s to establish these therapies as a foundational class of drugs for modern medicine
